Gonorrhea Clinical Trial
Official title:
Overall Patient Care in a Montpelier Sexual Health Center (CeGIDD). Response Rate to Ceftriaxone 1g IM in Gonorrhoea : a French Retrospective Monocentric Study
Sexual health centers (CeGIDD, in France) manage the majority of STI in France, especially gonorrhea. Patients wanting STI screening can consult either they are symptomatic or not. If they are symptomatic, they can be treated immediately. If they are not symptomatic, they must come back seven days after in order to get their results and to be treated if necessary. Before any treatment for gonorrhea, subjects should be sampled for bacterial culture in order to perform AMR surveillance. After every treatment for gonorrhea, subjects should realized a test of cure (TOC) according to current recommandation. Response rate to ceftriaxone 1g IM for treating gonorrhea has never been evaluated in France while being used widely over the past months. Compliance to current recommandation at CeGIDD Montpellier has never been evaluated. This study will assess the response rate to ceftriaxone 1g IM as gonorrhea treatment by realizing a test of cure 14 days after each treatment.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01439503 -
Safer Sex Program for Young African-American Men
|
Phase 2 | |
| Completed |
NCT00381992 -
Risk Assessment of Long-Haul Truck Drivers
|
N/A | |
| Completed |
NCT03294395 -
New AntiBiotic Treatment Options for Uncomplicated Anogenital GOnorrhoea
|
Phase 3 | |
| Not yet recruiting |
NCT06428643 -
A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
|
N/A | |
| Completed |
NCT03896776 -
A Pragmatic Trial of Two Strategies for Implementing an Effective eHealth HIV Prevention Program (Keep It Up! 3.0)
|
N/A | |
| Completed |
NCT03718806 -
Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin
|
Phase 1 | |
| Completed |
NCT04010539 -
A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea
|
Phase 3 | |
| Completed |
NCT00262106 -
Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
|
Phase 3 | |
| Completed |
NCT00187902 -
Evaluation of NAATs for Detection of C. Trachomatis and N. Gonorrhoeae From Pharynx, Rectum, Glans & Urethra of MSM
|
N/A | |
| Completed |
NCT00207506 -
Lay Health Advisors for Sexually Transmitted Disease Prevention
|
Phase 1/Phase 2 | |
| Completed |
NCT04553068 -
Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection
|
Phase 3 | |
| Active, not recruiting |
NCT03959527 -
Zoliflodacin in Uncomplicated Gonorrhoea
|
Phase 3 | |
| Active, not recruiting |
NCT03980223 -
Evaluation of Doxycycline Post-exposure Prophylaxis to Reduce Sexually Transmitted Infections in PrEP Users and HIV-infected Men Who Have Sex With Men
|
Phase 4 | |
| Completed |
NCT01465607 -
Implementation of an Efficacious Intervention for High Risk Women in Mexico
|
N/A | |
| Terminated |
NCT00120770 -
Cellulose Sulfate (CS) Gel and HIV in Nigeria
|
Phase 3 | |
| Completed |
NCT02391233 -
Multimedia WORTH With Black Drug-Involved Women on Probation
|
N/A | |
| Recruiting |
NCT05766904 -
Efficacy Trial on Meningococcal B Vaccine for Preventing Gonorrhea Infections
|
Phase 3 | |
| Completed |
NCT04297436 -
Gonococcal Vaccine Study in Key Populations in Kenya
|
N/A | |
| Completed |
NCT03098329 -
Check it: A New Approach to Controlling Chlamydia Transmission in Young People
|
N/A | |
| Completed |
NCT01836445 -
Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men
|
N/A |